Medical Professional Publications

Pharmacy and Therapeutics Committee Updates

(From the May 2017 Issue of MedStat)

The following actions were taken at the 4/6/17 Pharmacy & Therapeutics Committee meeting:

Benzodiazepine and Opioid Taper Guidelines for ICU Patients were APPROVED and will be posted on the Pharmacy Department intranet site

Medication stock list was APPROVED for the Pharmacist Code Violet Box

Mepolizumab (Nucala®) was ADDED to the formulary; use will be restricted to Pulmonology and Allergy & Immunology

Bevacizumab for treatment of recurrent respiratory papillomatosis will no longer require the informed consent per the Innovative Uses policy

Ondansetron IV Administration Guidelines were APPROVED and will be updated in the online Formulary

myChildren’s mobile app

iPhone and Android.

Download Today! »

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000